Showing 1 - 20 results of 37,165 for search '(( 4 nm decrease ) OR ((( 50 ((a decrease) OR (_ decrease)) ) OR ( _ web decrease ))))*', query time: 0.80s Refine Results
  1. 1

    Regions (α-helices, β-sheets, and loops) showing an average increase or decrease of RMSF in the MTs compared to the WT; RMSF of a particular structure is taken to be increased or decreased if there is an average change in RMSF of >0.03 nm in at least ≥50% of its residues. by Kumaraswamy Naidu Chitrala (612025)

    Published 2014
    “…<p>Regions (α-helices, β-sheets, and loops) showing an average increase or decrease of RMSF in the MTs compared to the WT; RMSF of a particular structure is taken to be increased or decreased if there is an average change in RMSF of >0.03 nm in at least ≥50% of its residues.…”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s. by Djaloul Karboua (16510091)

    Published 2023
    “…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…”
  7. 7
  8. 8
  9. 9
  10. 10

    AKT inhibition decreases neuroblast populations. by Maria R. Aburto (186884)

    Published 2012
    “…Otic vesicles were isolated from HH18 chicken embryos, made quiescent and cultured for 20 h in serum-free culture medium without additions (0S, a) or in the presence of IGF-I (10 nM, b), LY294002 (LY, 25 µM, c) or AKTi VIII (AKTi, 50 µM, d). …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

    Published 2012
    “…<p>Endothelial cells (1.0×10<sup>6</sup> cells) were plated in 35 mm<sup>2</sup> dishes coated with type I collagen and treated with 600 nM corticosterone for 48 hours. Whole cell lysates were used for qRT-PCR. …”
  16. 16

    Substance P decreases PRL immunoreactivity in human epidermis. by Ewan A. Langan (405804)

    Published 2013
    “…PRL IR was measured using Image J software, showing that (C) epidermal PRL IR was significantly decreased by 100 nM Substance P treatment (p = 0.009). …”
  17. 17
  18. 18
  19. 19

    Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 24h, 48h and 72h with 50 nM of siRNAs TMPRSS2-ERG III (1, 2, 3), siRNAs TMPRSS2-ERG IV (1, 2), siRNA against ERG wild type or siRNA Control. …”
  20. 20

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”